OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Orr on Ongoing Biomarker Research in Ovarian Cancer

January 28th 2020

Brian Orr, MD, an assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at University of Pittsburgh Medical Center, discusses ongoing biomarker research for immunotherapy in ovarian cancer.

Dr. Yorio on Treatment Options for Patients With Rare Mutations in Metastatic Lung Cancer

January 28th 2020

Jeff Yorio, MD, discusses treatment options for patients with rare mutations in metastatic lung cancer.

Dr. Moses On Ongoing Trials in mHSPC

January 28th 2020

Kelvin Alexander Moses, MD, PhD, discusses ongoing clinical trials in metastatic hormone-sensitive prostate cancer.

Dr. Weber on Adjuvant Approaches in Stage III Melanoma

January 27th 2020

Jeffrey S. Weber, MD, PhD, discusses adjuvant approaches in stage III melanoma.

Dr. Pavlick on Importance of Immunotherapy in Metastatic Melanoma

January 27th 2020

Anna C. Pavlick, DO, discusses the importance of immunotherapy for patients with metastatic melanoma.

Dr. Diefenbach on Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in FL

January 27th 2020

Catherine M. Diefenbach, MD, discusses polatuzumab vedotin (Polivy) plus obinutuzumab (Gazyva) and lenalidomide (Revlimid) in patients with follicular lymphoma.

Dr. Penson on Maintaining QoL With AR Inhibitors in Nonmetastatic CRPC

January 25th 2020

David F. Penson, MD, MPH, MMHC, discusses the importance of maintaining quality of life for patients treated with androgen receptor inhibitors in nonmetastatic castration-resistant prostate cancer.

Dr. Cheng on Molecular Testing Considerations in Prostate Cancer

January 25th 2020

Heather H. Cheng, MD, PhD, discusses considerations for molecular testing in prostate cancer.

Dr. Salani on Patient Selection for Primary Debulking Surgery in Ovarian Cancer

January 25th 2020

Ritu Salani, MD, discusses selecting patients with ovarian cancer for primary debulking surgery versus neoadjuvant chemotherapy.

Dr. Shinohara on the Future of Radiation and Surgery in Prostate Cancer

January 25th 2020

Eric Shinohara, MD, MSCI, discusses the future of stereotactic body radiation and surgery in prostate cancer.

Dr. Martin on Selinexor in Triple-Class Refractory Multiple Myeloma

January 25th 2020

Thomas G. Martin, MD, discusses the use of selinexor in patients with triple-class refractory multiple myeloma.

Dr. Sartor on Promising Treatment Approaches in Prostate Cancer

January 25th 2020

A. Oliver Sartor, MD, discusses research on immunotherapy, radiopharmaceuticals, and combinations in prostate cancer.

Genomic Sequencing and Identifying Driver Mutations in AML and MDS

January 25th 2020

Ilaria Iacobucci, PhD, discusses integrated transcriptomic and genomic sequencing to identify prognostic constellations of driver mutations in AML and MDS.

Dr. Tolaney on the Advantages of ctDNA Versus Tissue Biopsy in Breast Cancer

January 25th 2020

Sara M. Tolaney, MD, MPH, discusses the advantages of circulating tumor DNA versus tissue biopsy in breast cancer.

Dr. Penson on Questions Regarding Next-Generation AR Inhibitors in Prostate Cancer

January 25th 2020

David F. Penson, MD, MPH, MMHC, discusses questions regarding next-generation androgen receptor (AR) inhibitors in prostate cancer.

Dr. Kohli on Drugs That Have Been Evaluated in mCRPC

January 25th 2020

Manish Kohli, MD, discusses drugs that have been evaluated in metastatic castration-resistant prostate cancer.

Dr. Cosgrove on the Approval of Niraparib in Advanced Ovarian Cancer

January 24th 2020

Casey M. Cosgrove, MD, discusses the approval of niraparib in advanced ovarian cancer.

Dr. Rampal on Ongoing Research With Pacritinib in Myelofibrosis

January 24th 2020

Raajit K. Rampal, MD, PhD, hematologic oncologist, Memorial Sloan Kettering Cancer Center, discusses ongoing research with pacritinib in myelofibrosis.

Dr. Hwang on Treatment Selection in Metastatic Castration-Sensitive Prostate Cancer

January 24th 2020

Clara Hwang, MD, a medical oncologist with Henry Ford Health System, discusses treatment selection in newly diagnosed metastatic castration-sensitive prostate cancer (mCSPC).

Dr. Fakhri on the Use of PI3K Inhibitors in Relapsed/Refractory CLL

January 24th 2020

Bita Fakhri, MD, MPH, assistant professor of medicine in the Division of Hematology/Oncology at the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, discusses the use of PI3K inhibitors in relapsed/refractory chronic lymphocytic leukemia (CLL).